Clinical benefit of the gedatolisib regimens was consistent across patient subgroups Hyperglycemia was reported in only 9.2% of patients treated with gedatolisib + palbociclib + fulvestrant ...

BERLIN -- Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly ...

Combining the PARP1-selective inhibitor saruparib with an androgen receptor pathway inhibitor (ARPI) demonstrated promising efficacy and safety in patients with metastatic prostate cancer, according ...

The triplet regimen of berdomide, daratumumab (Darzalex), and dexamethasone has led to deepening responses in newly diagnosed, transplant-ineligible patients with multiple myeloma.

Anbenitamab (KN026) is an anti-HER2 bispecific antibody independently developed by Alphamab Oncology using the proprietary Fc-based heterodimer bispecific platform technology called CRIB (Charge ...

Ohtani had already had an impressive start to his second career postseason pitching start, working around a leadoff walk to ...

Will Caleb Williams play against the New Orleans Saints today? The Chicago Bears quarterback addresses criticism, practice ...

NFL.com breaks down three must-know storylines for Sunday's international game between the Los Angeles Rams and Jacksonville ...

Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated ...

Results from day one of round eleven of the Bennetts British Superbike Championship, returning to Brands Hatch for the ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...